Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
0.366 0.006 (1.58%)
Jan 19, 2022 9:30 AM EST - Market open
Market Cap44.41M
Revenue (ttm)3.34M
Net Income (ttm)-69.16M
Shares Out121.40M
EPS (ttm)-0.77
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume42,215
Open0.362
Previous Close0.360
Day's Range0.362 - 0.370
52-Week Range0.358 - 3.770
Beta0.95
AnalystsBuy
Price Target2.83 (+673.6%)
Earnings DateNov 2, 2021

About AGRX

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a reg...

IndustryPharmaceuticals
IPO DateMay 23, 2014
CEOAlfred Altomari
Employees28
Stock ExchangeNASDAQ
Ticker SymbolAGRX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for AGRX stock is "Buy." The 12-month stock price forecast is 2.83, which is an increase of 673.65% from the latest price.

Price Target
$2.83
(673.65% upside)
Analyst Consensus: Buy

News

Agile Therapeutics Acknowledges New Government Guidance Reinforcing Requirement to Cover Contraceptives that a Woman ...

PRINCETON, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- On January 10, 2022, the tri-agencies, Department of Labor (DOL), Health and Human Services (HHS) and Treasury issued new guidance that supports women'...

6 days ago - GlobeNewsWire

Agile Therapeutics and Afaxys Partner to Expand Access to Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal ...

PRINCETON, N.J. and CHARLESTON, S.C., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a new alliance with Afaxys Pharma, LLC to p...

1 week ago - GlobeNewsWire

Agile Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will prese...

2 weeks ago - GlobeNewsWire

Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect Virtual Conferences

PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will present at...

2 weeks ago - GlobeNewsWire

Penny Stocks To Buy For Under $1 & What To Watch Right Now

Looking for cheap penny stocks to buy? Here are 4 to watch trading below $1 right now.

Other symbols:GTEMTNBPTN
1 month ago - PennyStocks

Top Penny Stocks For Your Under $1 List Right Now

Check these Under $1 penny stocks out for your watchlist The post Top Penny Stocks For Your Under $1 List Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:ADMPBRQS
1 month ago - PennyStocks

Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 5.26% and -13.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Agile Therapeutics Reports Third Quarter 2021 Financial Results

Prescription Demand Growth Continues in the Third Quarter 2021 with a 61% Increase in Twirla Cycles Dispensed

2 months ago - GlobeNewsWire

Agile Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on Tuesday, November 2,...

Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET

2 months ago - GlobeNewsWire

Top Penny Stocks to Watch Making Big Moves Right Now

If you're making a penny stocks watchlist right now, check these three small-caps out The post Top Penny Stocks to Watch Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:ADMPDNN
3 months ago - PennyStocks

Best Biotech Penny Stocks on Reddit to Buy Now? 4 For Your Watchlist

Looking for biotech penny stocks to watch on Reddit? Check these four out for your list The post Best Biotech Penny Stocks on Reddit to Buy Now?

Other symbols:KTRAPROGSESN
3 months ago - PennyStocks

Agile Therapeutics Applauds Congressional Chairs' Letter to Biden Administration Requesting Enforcement of Contracept...

PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today applauded House Congressional Committee leaders in urging the Secretaries ...

3 months ago - GlobeNewsWire

Agile Therapeutics Appoints Josephine Torrente to its Board of Directors

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Josephine Torrente has been appointed to the Company's boar...

3 months ago - GlobeNewsWire

Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants

PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 sh...

3 months ago - GlobeNewsWire

Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants

PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it intends to offer and sell shares of its common stock and...

3 months ago - GlobeNewsWire

Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary

Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021 Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021

3 months ago - GlobeNewsWire

Agile Therapeutics to Participate in Upcoming Investor Conferences

PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following v...

4 months ago - GlobeNewsWire

Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women's Access to Twirla® (levonorges...

PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth service, ...

4 months ago - GlobeNewsWire

2 Penny Stocks Insiders Are Buying

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...

Other symbols:MINM
5 months ago - Benzinga

Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 4.76% and -18.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Agile Therapeutics: Q2 Earnings Insights

Shares of Agile Therapeutics (NASDAQ:AGRX) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 66.67% year over year to ($0.20), which beat the ...

5 months ago - Benzinga

Agile Therapeutics Reports Second Quarter 2021 Financial Results

Total Prescriptions (TRx) Grew 171% in Second Quarter

5 months ago - GlobeNewsWire

Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021

Live Conference Call and Webcast at 4:30 p.m. EDT Live Conference Call and Webcast at 4:30 p.m. EDT

6 months ago - GlobeNewsWire

Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference

PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the company will be participating virtually in the William Blair ...

7 months ago - GlobeNewsWire

Agile Therapeutics (AGRX) Reports Q1 Loss, Lags Revenue Estimates

Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 9.09% and -82.10%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research